Catabasis Pharma (CATB) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CATB Hot Sheet
Join SI Premium – FREE
Catabasis Pharma (NASDAQ: CATB) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
